NCI-MATCH EAY131-Z1I: Phase II study of AZD1775, a wee-1 kinase inhibitor, in patients with tumors containing BRCA1 and BRCA2 mutations Kummar, S., Li, S., Reiss, K., Ford, J. M., Mitchell, E. P., Zwiebel, J. A., Takebe, N., Gray, R. J., McShane, L. M., Rubinstein, L. V., Patton, D., Williams, P., Hamilton, S. R., Brufsky, A., Conley, B. A., Arteaga, C. L., Harris, L. N., O'Dwyer, P. J., Chen, A. P., Flaherty, K. T. AMER ASSOC CANCER RESEARCH. 2019

View details for DOI 10.1158/1538-7445.AM2019-CT138

View details for Web of Science ID 000488129900123